Protocols for Bladder Cancer
| HIC 0609001823 Wm. Kevin Kelly M.D. A Phase II Multicenter Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naïve Patients with Advanced, Metastatic Bladder Carcinoma |
| HIC 0609001823 Wm. Kevin Kelly M.D. A Phase II Multicenter Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naïve Patients with Advanced, Metastatic Bladder Carcinoma |